𝔖 Bobbio Scriptorium
✦   LIBER   ✦

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk

✍ Scribed by Cheng, I; Liu, X; Plummer, S J; Krumroy, L M; Casey, G; Witte, J S

Book ID
109999216
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
91 KB
Volume
97
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic variation in the COX-2 gene and
Genetic variation in the COX-2 gene and the association with prostate cancer risk
✍ K. Shahedi; S. Lindström; S.L. Zheng; F. Wiklund; J. Adolfsson; J. Sun; K. Augus 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 2 views

## Abstract COX‐2 is a key enzyme in the conversion of arachidonic acid to prostaglandins. The prostaglandins produced by COX‐2 are involved in inflammation and pain response in different tissues in the body. Accumulating evidence from epidemiologic studies, chemical carcinogen‐induced rodent model

Mannose-binding lectin-2 genetic variati
Mannose-binding lectin-2 genetic variation and stomach cancer risk
✍ Andrea Baccarelli; Lifang Hou; Jinbo Chen; Jolanta Lissowska; Emad M. El-Omar; P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB

## Abstract Deficiency of the mannose‐binding lectin (MBL) protein, an antigen‐recognition molecule involved in systemic and mucosal innate immunity, is determined by variant alleles in __MBL2__ gene promoter and exon‐1 regions. We conducted a population‐based study on 305 stomach cancer cases and